The nuclear protein PARP1 has a well-established role in the signaling and repair of DNA, and is a validated therapeutic target for cancers and other human diseases.390 Cancer cells bearing mutations in BRCA1 or BRCA 2 are exquisitely sensitive to PARP1 inhibitors, which is called synthetic lethality. This evidence concerns the gene BRCA1 and cancer.